BeOne Medicines AG annual free cash flow for fiscal 2025 was $861 million, compared with -$670 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $861M | ($670M) | ($1.8B) | ($2.0B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | $415M | $160M | $380M | $354M | $200M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More 6160 metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All 6160 financial statements → Interactive 6160 charts →
About TickerBase · Data methodology & sources · Privacy · Terms